Printer Friendly

Harvard Bioscience receives 'notice of allowability' for organism sorting technology.

Harvard Bioscience, Inc. (Holliston, MA; 508-893-8999) announced the receipt of a "Notice of Allowability" from the United States Patent and Trademark Office for its key model organism sorting technology, known as COPAS. The COPAS technology enables the high throughput/high content analysis and sorting of model organisms such as the fruit fly, D. melanogaster, the nematode worm, C. elegans, and the zebrafish, D. rerio. These model organisms are increasingly being used by pharmaceutical and biotechnology companies for target validation, efficacy screening and ADMET screening in drug discovery, and by university researchers in basic genetic and genomic research. The COPAS technology can also be used to sort beads used in combinatorial chemistry at record speeds such as in the recently announced work with the Carlsberg Institute. COPAS instruments and systems are sold through Harvard Bioscience's Union Biometrica subsidiary.

David Green, President of Harvard Bioscience commented: "We are very pleased to receive this "Notice of Allowability". It confirms the uniqueness of the inventions we have made for high throughput drug discovery. This is only one of several patent applications we have before the USPTO."

Harvard is a global developer, manufacturer and marketer of innovative, enabling tools in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. HBIO sells approximately 10,000 products to thousands of researchers in over 60 countries though its direct sales force, 1,000 page catalog, and through its distributors, the most notable of which is AP Biotech. HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany and Belgium with sales facilities in France and Canada.
COPYRIGHT 2001 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:Harvard Bioscience receives 'notice of allowability' for organism sorting technology.
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:1USA
Date:Oct 1, 2001
Previous Article:MorphoSys issued patent for HuCAL antibody library.
Next Article:Paradigm Genetics receives herbicide target patent.

Related Articles
Harvard Bioscience acquires electrophoresis company. (Executive Briefing: news, trends & market intelligence for instrument executives).
Harvard Bioscience acquires spectrophotometer company. (Executive Briefing).
Harvard bioscience revises forecast. (Executive briefing: news, trends & market intelligence for instrument executives).
Harvard Bioscience sticks to its strategy.
Light BioScience receives 'Notice of Allowance' of photomodulation patent.
Axon and Harvard Bioscience settle with Oxford Gene Technologies. (Executive briefing: news, trends & market intelligence for instrument executives).
2003 litigation update.
Harvard Bioscience rejects buyout offer and sells businesses.
Harvard Bioscience expands in Spain.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters